{
    "nctId": "NCT01813825",
    "briefTitle": "A Single Site Prospective, Non-randomized Study of Partial Breast Intracavitary Brachytherapy Devices to Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities.",
    "officialTitle": "N/A",
    "overallStatus": "UNKNOWN",
    "conditions": "This Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting.",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "A Single Site Prospective, Non Randomized Study of Partial Breast Intracavitary Brachytherapy Devices To Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Be 45 years of age or older\n* Be a Tis, T1, N0 M0 - American Joint Committee Classification\n* Have negative surgical margins (NSABP definition) after final surgery\n* Should have adequate skin spacing between balloon surface and surface of the skin (\\>=7mm)\n* DCIS\n\nExclusion Criteria:\n\n* Be pregnant or breast-feeding.(If appropriate, patient must use birth control during the study)\n* Have collagen-vascular disease\n* Have extensive intraductal component (Harvard Definition,\\>25% DCIS)\n* Have infiltrating lobular histology",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}